#Tocalizumab

Exciting results from the #RECOVERY trial #preprint of #Tocalizumab (Toci) in hospitalized people w/ #COVID19-reduced 28-day mortality (29 vs 33%; NNT)-decreased likelihood of requiring MV (33% vs 38%)-shorter hospital stay
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.